These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Cardiological Challenges Related to Long-Term Mechanical Circulatory Support for Advanced Heart Failure in Patients with Chronic Non-Ischemic Cardiomyopathy. Dandel M J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892589 [TBL] [Abstract][Full Text] [Related]
45. Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support. Grabellus F; Levkau B; Sokoll A; Welp H; Schmid C; Deng MC; Takeda A; Breithardt G; Baba HA Cardiovasc Res; 2002 Jan; 53(1):124-30. PubMed ID: 11744020 [TBL] [Abstract][Full Text] [Related]
46. The Effect of Left Ventricular Assist Device Therapy on Cardiac Biomarkers: Implications for the Identification of Myocardial Recovery. Holzhauser L; Kim G; Sayer G; Uriel N Curr Heart Fail Rep; 2018 Aug; 15(4):250-259. PubMed ID: 29971612 [TBL] [Abstract][Full Text] [Related]
47. Shared Care to Destination Therapy Left Ventricular Assist Device Site: a Novel Strategy to Start a Successful Mechanical Circulatory Support Program. Shah M; Hafeez Y; Burns P; Toyoda Y; Moshiyakhov M; Neary M; Ross R; Chichetti J; Muzaffar A; Barn K Curr Cardiol Rep; 2021 Jul; 23(8):112. PubMed ID: 34264422 [TBL] [Abstract][Full Text] [Related]
49. Circulating and Myocardial Cytokines Predict Cardiac Structural and Functional Improvement in Patients With Heart Failure Undergoing Mechanical Circulatory Support. Diakos NA; Taleb I; Kyriakopoulos CP; Shah KS; Javan H; Richins TJ; Yin MY; Yen CG; Dranow E; Bonios MJ; Alharethi R; Koliopoulou AG; Taleb M; Fang JC; Selzman CH; Stellos K; Drakos SG J Am Heart Assoc; 2021 Oct; 10(20):e020238. PubMed ID: 34595931 [TBL] [Abstract][Full Text] [Related]
50. Mast cell-derived cathepsin g: a possible role in the adverse remodeling of the failing human heart. Jahanyar J; Youker KA; Loebe M; Assad-Kottner C; Koerner MM; Torre-Amione G; Noon GP J Surg Res; 2007 Jun; 140(2):199-203. PubMed ID: 17418861 [TBL] [Abstract][Full Text] [Related]
52. Transcriptional patterns of reverse remodeling with left ventricular assist devices: a consistent signature. Ton VK; Vunjak-Novakovic G; Topkara VK Expert Rev Med Devices; 2016 Nov; 13(11):1029-1034. PubMed ID: 27685648 [TBL] [Abstract][Full Text] [Related]
53. Heterotopic transplantation of the failing rat heart as a model of left ventricular mechanical unloading toward recovery. Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Ikeda T; Nishimura K; Komeda M ASAIO J; 2005; 51(1):116-20. PubMed ID: 15745145 [TBL] [Abstract][Full Text] [Related]
54. Combining Stem Cell Therapy for Advanced Heart Failure and Ventricular Assist Devices: A Review. Reich HJ; Czer LSC; Ramzy D; Arabia F; Moriguchi J; Ascheim DD; Henry TD ASAIO J; 2018; 64(5):e80-e87. PubMed ID: 29538018 [TBL] [Abstract][Full Text] [Related]
55. Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure. Lee SH; Doliba N; Osbakken M; Oz M; Mancini D J Thorac Cardiovasc Surg; 1998 Aug; 116(2):344-9. PubMed ID: 9699589 [TBL] [Abstract][Full Text] [Related]
58. Mechanical Circulatory Support Therapy in the Cardiac Intensive Care Unit. Schroeder SE Nurs Clin North Am; 2023 Sep; 58(3):421-437. PubMed ID: 37536790 [TBL] [Abstract][Full Text] [Related]
59. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Dipla K; Mattiello JA; Jeevanandam V; Houser SR; Margulies KB Circulation; 1998 Jun; 97(23):2316-22. PubMed ID: 9639375 [TBL] [Abstract][Full Text] [Related]
60. Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in heart failure. Miyagawa S; Toda K; Nakamura T; Yoshikawa Y; Fukushima S; Saito S; Yoshioka D; Saito T; Sawa Y Surg Today; 2016 Feb; 46(2):149-54. PubMed ID: 25840890 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]